Replies to post #370512 on Innovation Pharmaceuticals Inc (IPIX)

[CallMeCrazy]

That is not what I said:

You said:

If the asset (B) is so "easily valued", for so many indications over numerous years, why haven't the big boys' ponied up?

I said:

When a company has an asset that others in the industry can easily value in the billion$...funding is not a problem.

The answer to your question is COVID-19 that arrived in 2020. B-COVID's value, presuming good P-2 results, will become obvious because there is no effective-approved therapeutic for COVID-19 and there are roughly 7B unvaccinated people on Earth.

You talk about "so many indications" and I'm only talking about one...B-COVID, an indication that world seems ready to do some big time spending on through 2025:

Total global spending on COVID-19 vaccines is projected to reach $157 billion by 2025, driven by mass vaccination programs underway and "booster shots" expected every two years, according to a report by U.S. health data company

https://www.reuters.com/business/healthcare-pharmaceuticals/world-spend-157-billion-covid-19-vaccines-through-2025-report-2021-04-29/

So, nearly 7B people around the world is unvaccinated. The WORLD plans to spend $157B on COVID through 2025 There is a great need for COVID therapeutics and the ONLY U.S. approved therapeutic, though ineffective (according to The WHO), made nearly $5B between its P-2 and FDA approval and once B-COVID is proven to be effective, you think BP, "asleep at the switch", will not be interested? WOW!

I don't believe what I want. I believe what the evidence suggest.

Message in reply to:

"Leo is in the driver's seat and he knows it. I believe Leo has been engaged in talks with various BP for quite some time because part of the EUA process is to show how you plan to manufacture and distribute the authorized drug and the U.S. Gov't has a lot say in these areas.

"When a company has an asset that others in the industry can easily value in the billion$...funding is not a problem."

If the asset (B) is so "easily valued", for so many indications over numerous years, why haven't the big boys' ponied up?

We all believe what we want.

Hopefully the B for C results are good and do not become a footnote in the Septembers 10K (or later 10 q's).

GLTU